CASI Pharmaceuticals Inc. (CASI)
(Delayed Data from NSDQ)
$5.35 USD
-0.16 (-2.90%)
Updated Sep 25, 2024 01:01 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (87 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.58 | 9.99 |
Current Quarter Estimate | NA | -1.06 | 61.00 |
Year Ago Quarter Estimate | -0.35 | -0.06 | 54.84 |
Next Quarter Estimate | NA | -1.85 | 63.00 |
Next Year Estimate | NA | 12.67 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 20.20 | 15.70 |
Next Year | NA | 15.90 | 11.30 |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.82 |
Price/Book (MRQ) | 8.19 | 1.65 |
Price/Cash Flow (MRFY) | NA | 8.75 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -118.81% | -58.89% |
Return on Equity (TTM) | -126.20% | -58.88% |
Debt to Equity (MRQ) | 2.05 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.